subtilisin


Also found in: Medical, Wikipedia.
Related to subtilisin: trypsin

sub·til·i·sin

 (sŭb-tĭl′ĭ-sĭn)
n.
Any of several extracellular enzymes produced by bacteria of the genus Bacillus that catalyze the breakdown of proteins into polypeptides and are widely used in detergents and cleaning products.

[New Latin (Bacillus) subtīlis, bacterial species to which were assigned the bacteria from which a subitilisin was first isolated (now known to be B. amyloliquefaciens); see subtilin + -in.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

subtilisin

(sʌbˈtɪlɪsɪn)
n
any of various protease enzymes originally derived from Bacillus subtilis
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014
References in periodicals archive ?
The multi-enzyme formulation is subtilisin free and has been independently tested and classified as non-irritating to both the eyes and skin.
TUESDAY, July 23, 2019 (HealthDay News) -- Patients with rejected or abandoned prescriptions for proprotein convertase subtilisin kexin type 9 inhibitors (PCSK9i) have a significantly increased risk for cardiovascular events than those with paid prescriptions, according to a study published online July 23 in Circulation: Cardiovascular Quality and Outcomes.
The discovery of proprotein convertase subtilisin kexin 9 (PCSK9) by Abifadel et al.
The RXRR sequence has been predicted as a consensus sequence in the Vtg protein for the recognition site by furin, a proprotein-converting enzyme that is structurally related to bacterial subtilisin (Hosaka et al., 1991).
Enter a new class of drugs--proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors--which, according to a Cleveland Clinic expert, have the potential to change the landscape of LDL management and, possibly, cardiovascular risk reduction.
To do this they are developing injectable monoclonal antibodies against a newly discovered protein known as proprotein convertase subtilisin kexin 9, which dramatically reduces the amount of LDL cholesterol circulating in the bloodstream.
antarctica strain PI12 with nine other subtilisin serine proteases from different families is shown in Table 2.
solani isolate from tomato in medium, containing heat-stable potato proteins, due to the presence among these proteins of a large amount trypsin and subtilisin inhibitors [34, 35].
The subtilisin protease family Pr1 is the main enzyme produced by entomopathogenic fungi during the infection process, although the trypsin- like protease Pr2 is the first to appear during in vitro growth on the cuticle (Gillespie et al., 1998).
Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease.